chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body aches; Low grade fever; Headache; Nausea; An elevated heart rate; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were unknown) via an unspecified route of administration, on 07Jan2021, at a single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received COVID-19 vaccine yesterday (07Jan2021). Ten hours later, he noticed body aches, low grade fever, headache, nausea, and an elevated heart rate. He is concerned on how long these symptoms last. Outcome of the events was unknown.  Information about lot/batch number has been requested.
Palpitations & Angina Narrative: Recommended ER visit, and refused this. Received #2 dose Moderna covid vaccine on 1/26/21. Did not report adverse reaction until TODAY to employee health, 8/12/2021. Recalls 2 day after vaccination on 1/28/21 noticed palpitations, chest tightness, nausea chills headaches nausea, near syncopal event denies loss of consciousness. Employee states she called sick to work for 2 days. Employee states came back to work with headache chills nausea resolved. She noticed intermittent sharp tightening in chest has been ongoing. Employee reports in March and April 2021 had palpitations intermittently, which she reports resolved in April 2021. She followed up with her PMD, he did the following workup- treadmill and echocardiogram ecg, she states all had normal findings. Denies nausea jaw pain or pain radiating to arms shoulders syncope unintentional wt gain 5 # or more overnight, denies shortness of breath with exertion denies orthopnea Past medical history + palpitations, pvc's
Pt experienced discomfort about 2 minutes after getting Moderna Covid Vaccine. She complained of Facial swelling, throat swelling, feeling hot, and difficulty breathing. Pt was closely observed for minutes and she recovered quickly. Her pulse and blood pressure were 110/79 and 92 respectively. EMS was called but she had already recovered when they came in about 10 minutes time. No treatment was given.
flu; Initial information received on 21-Dec-2022 regarding an unsolicited valid social media non-serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced flu after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.    On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site for flu (Influenza immunisation).  On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown for the event flu.
Received Moderna booster on Friday 3 December at local military establishment (husband works for that location) in left arm.  Friday 10 December noticed a few dots on left arm. Saturday 11 December evening began breaking out with rash hive  like reaction that began on my left arm where shot was received. Treated with over the counter medication from PX. The reaction continued to move and progress  to most places on my body including both arms, my eyes, ears, groin area, neck, hair, and body.  Went to the nearest Hospital ER.  Given IV with saline, cortisone, and anti-histamine. Hives began to clear up, but new ones began to form. Released from Hospital told it would take a day to resolve hives. As of Wednesday 15 old hives have subsided, but still suffering from progressing  of hives.  Very itchy and painful. OTC meds providing little to no relief.
was not able to eat and drink; so tired; projectile vomiting; slept 18 hours; severely sick; diarrhea; Loss of energy; feeling drained; severe tiredness; This spontaneous case was reported by a patient and describes the occurrence of VOMITING PROJECTILE (projectile vomiting), HYPERSOMNIA (slept 18 hours), ILLNESS (severely sick), DIARRHOEA (diarrhea) and ASTHENIA (Loss of energy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced FATIGUE (severe tiredness). On 06-May-2021, the patient experienced FATIGUE (feeling drained). On 07-May-2021, the patient experienced VOMITING PROJECTILE (projectile vomiting), HYPERSOMNIA (slept 18 hours), ILLNESS (severely sick), DIARRHOEA (diarrhea), ASTHENIA (Loss of energy) and FATIGUE (so tired). On an unknown date, the patient experienced EATING DISORDER (was not able to eat and drink). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-May-2021, VOMITING PROJECTILE (projectile vomiting), HYPERSOMNIA (slept 18 hours), ILLNESS (severely sick) and DIARRHOEA (diarrhea) had resolved. At the time of the report, ASTHENIA (Loss of energy), EATING DISORDER (was not able to eat and drink), FATIGUE (severe tiredness), FATIGUE (feeling drained) and FATIGUE (so tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included Allergy medications.
SHINGLES; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced shingles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of shingles was not reported. This report was non-serious.
Pt received DTaP 5th dose on LD on 6/30/04-on 7/1/04 mother noticed child LD red, swollen, hot to touch, some fever. Child fine today still has some redness. Child doing good otherwise.
Intolerable body aches, severe pain mostly in bones from knees  level to feet,  chills, severe headache, nausea, fever, extreme fatigue. Injection site:  whole arm referred pain and numbness.  Symptoms did not resolve  after taking 3 tablets of 650mg of Tylenol . 4 tablet of 250mg of Naproxen was way more helpful than Tylenol.
Patient received inappropriate vaccine for his age at the time.  Patient was 16 years old.  Nothing happened to the patient. He received both doses.  Patient is doing well.
Received my Moderna booster just over 6 months after receiving 2 dose Moderna vaccine in left shoulder. Felt fine for the 1st 24hrs they my left shoulder started to ache in the joint to the point I couldn't stand it. I took about 3 Tylenol 3 pills and sat up all night in a chair in searing pain. After about 12hrs the pain started to subside to a dull ache. For the next few days I couldn't raise my arm without extreme pain but it felt OK if I didn't move it. I also had hip joint pain and felt exhausted. Now I am on day 6 and I would say at about 90% good. I am very fit and work out everyday. I wear a mask everywhere so I don't think I caught anything else. My right shoulder joint never hurt.
She got her vaccine, was really tired and her arm was hurting.  Went to bed, and woke up in the morning at 4:00 AM with vaginal bleeding one episode.   Then it stopped and then she had a reoccurrence on 4/26/21, 4/27/21 and again on 4/28/21 and then it stopped again.   Had slight cramping.  No problems from the vaccine site itself.
pt recieved Dtap IM on 06/07/2023 but was not to receive the dose until 12/17/2024 per Health records
Systemic: Bell's Palsy-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild
lethargic underarm itchy 20 minutes after injection underarm on left side developed a rash
Developed fever, chill, headache, metallic taste in mouth on 4/12/21, resolved by 4/20/21
This spontaneous report was received from a health professional refers to unspecified patients of unknown demographics. On unspecified dates these patients were administered with unspecified doses of MMR II (lot # and expiry date unspecified) which was improperly stored throughout March 2015. No adverse effects were reported. Outcome of the event was unknown. Reporting health professional considered the event to be not related to MMR II. This is one of several reports from the same reporter (MARRS # 1503USA013938, MARRS # 1503USA014260, MARRS # 1503USA014261, MARRS # 1503USA014262, MARRS # 1503USA014264 and MARRS # 1503USA014265. Additional information has been requested.
Swollen Left Lymph node, 100.2 degree fever starting on 05/03/2011
Swelling and a little rash on the (L) deltoid area 2 days after receiving DTaP. Received KEFLEX (by mouth), ointment applied warm compress/ibuprofen. Reaction improved dramatically the next day.
approximately 12 hrs. after receiving shot, i woke up because of being extremely cold, could not warm up or sleep, took temp 4 hrs later and was 100.8, experienced difficulty even walking at that time muscles all thru body hurt. Headache that i already had previous to shot became worse.  Took tylenol for fever. pain and fever subsided in less than 24 hrs from onset.  Contacted pharmacy regarding adverse reaction and neurologist i had seen the previous week.
Within 24 hrs sore throat, cough, sinus discharge. Still having cough and sinus symptoms going on 2 wks.
On the day of administration, the Moderna vaccine was past its 30 days of refrigeration. We reached out to the manufacturer and they responded with the following, "Thank you for your patience. Analysis of the vials associated with your storage excursion is complete. The vaccine administered on February 14, 2022, February 15, 2022, February 16, 2022, February 18, 2022, and February 21, 2022 from lot number 042J21A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration".
Information has been received from a physician and a medical assistant concerning a 7 year old female, weight 46lb, who on 19-JUL-2001 was vaccinated with the first dose of VARIVAX vaccine (Merck) (lot#: 635792/1893K) and on 04-DEC-2006 at 15:00 was vaccinated with a second dose of VARIVAX vaccine (Merck) in the left arm (lot#: 654748/1060F). The 04-DEC-2008 at 15:00 the patient was also vaccinated with the first dose of HAVRIX vaccine in the left arm. On 27-APR-2008 the patient developed multiple chickenpox lesions on her trunk. On 28-APR-2008 the patient was seen in the physician's office. She also had headache, sore throat and no fever. On approximately 04-May-2008 the patient recovered. The patient was exposed to her grandfather who had a shingles outbreak recently. Her 1 brother and 1 sister also developed chickenpox after vaccination. (WAES#: 0804USA06382 and 0805USA05059).  Additional information is not expected.
No adverse event occurred.  Child was given Kinrix which has DTaP and IPV in it and IPV.  This meant that the child received an extra dose of polio vaccine.  I spoke to the family the next day and they reported a tactile fever that night.  Next day no symptoms.
Pt recv vax on 11/17/98; on 11/18/98 pt exp redness/erythema x 2-3 hr & nausea
Patient reports injection site pain and redness at injection site. Also complains of nausea and vomiting 1 day after receiving 2nd dose of vaccine. Asymptomatic with 1st dose. Symptoms resolved on day 2 after receiving vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), on 01May2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 75 years for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient had not received other medication in 2 weeks.Patient received Paxlovid for COVID 19 treatment from 05May2023 to 10May2023. Patient had not taking any other medications/products within 2 weeks of starting COVID-19 treatment. Patient previously receive a COVID-19 Vaccine. No known allergies was reported.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
vaccine that was in the fridge for 35 days; No adverse event; Dose administered after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (vaccine that was in the fridge for 35 days) and NO ADVERSE EVENT (No adverse event) in a 13-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Apr-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 05-Apr-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine that was in the fridge for 35 days) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (vaccine that was in the fridge for 35 days) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (vaccine that was in the fridge for 35 days).    Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant medication were reported.  The patient's previous COVID19 history was unknown. No adverse reaction reported.  The vial was initially stored in the refrigerator on 27-Feb-2023. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter.
9/26/19: PAIN AT INJECTION SITE, SWELLING, SORENESS, HEADACHE.  LIMITED MOVEMENT OF LEFT SHOULDER JOINT. SEVERE PAIN WHEN RAISING ARM OR REACHING BEHIND. UNABLE TO SLEEP DUE TO PAIN. TREATED WITH NAPROXEN 220 mg. 9/27/19: CONTINUED LIMITED MOVEMENT OF LEFT SHOULDER JOINT. SEVERE PAIN WHEN RAISING ARM OR REACHING BEHIND. CONTINUED HEADACHE. RESTED ALL DAY AND DID NOT USE SHOULDER JOINT. NAPROXEN 220 mg. X 2 9/28/19 to PRESENT:  LIMITED MOVEMENT OF LEFT SHOULDER JOINT. CONTINUING PAIN WHEN RAISING ARM OR REACHING BEHIND. WEAKNESS IN LEFT ARM WHEN SHOULDER JOINT HAS ROLE IN TASK. TAKING NAPROXEN AND RESTRICTING MOVEMENT OF LEFT SHOULDER AS MUCH AS POSSIBLE
If she had allergic reactions to both shots; she didn't feel well; tired; memory issues; lips got tingly; lips got swollen; face was bright red; face was swollen; She had the munchies; She had nasal congestion/sounded congested; she felt manic (hyper) for 12 hours; arm was sore; got confused; spacy; dry patches on her skin at her ankle and the side of her head; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen) and HUNGER (She had the munchies) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 10-Feb-2021, the patient experienced PARAESTHESIA ORAL (lips got tingly), LIP SWELLING (lips got swollen), ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), HUNGER (She had the munchies), NASAL CONGESTION (She had nasal congestion/sounded congested), MANIA (she felt manic (hyper) for 12 hours), PAIN IN EXTREMITY (arm was sore), CONFUSIONAL STATE (got confused), FEELING ABNORMAL (spacy), MEMORY IMPAIRMENT (memory issues) and FATIGUE (tired).   On 12-Feb-2021, the patient experienced MALAISE (she didn't feel well). In February 2021, the patient experienced DRY SKIN (dry patches on her skin at her ankle and the side of her head).   On an unknown date, the patient experienced DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots).   On 11-Feb-2021, ERYTHEMA (face was bright red), SWELLING FACE (face was swollen), CONFUSIONAL STATE (got confused) and FEELING ABNORMAL (spacy) outcome was unknown.   On 12-Mar-2021, MALAISE (she didn't feel well) outcome was unknown.   On 19-Mar-2021, HUNGER (She had the munchies) and MANIA (she felt manic (hyper) for 12 hours) outcome was unknown.   On 19-Apr-2021, FATIGUE (tired) outcome was unknown.   At the time of the report, DRY SKIN (dry patches on her skin at her ankle and the side of her head), MEMORY IMPAIRMENT (memory issues) and DRUG HYPERSENSITIVITY (If she had allergic reactions to both shots) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD21-089812, MOD21-089813, US-MODERNATX, INC.-MOD-2021-123936 (E2B Linked Report).  This case was linked to MOD-2021-123493, MOD-2021-123493 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes:  On 12-May-2021: TCR document; Sender's Comments:  MOD21-089812:Same reporter MOD21-089813:Same reporter US-MODERNATX, INC.-MOD-2021-123936:crosslinked
Awakened at 3AM , approximately 12 hours post injection,with severe headache, chills, and body aches.  Headache , chills, and body aches continued all day May 1, 2019. Fever of 100.6 F appeared approximately 24 hours post injection   Returned to normal temperature by 9 pm  May 1.  Treated with 1000 mg Tylenol every 6 hours.
6/14/07 - the day after HPV #1 given, developed severe pain (10/10) at injection site on upper arm that extended down her entire right arm. No numbness or motor loss. Pain resolved after about 3 days. 8/14/07 - 2-3 days after HPV #2 given, developed pain along her entire arm and the thigh of the side on which she was injected. Also developed swelling of eye on affected side with tearing and redness. No rash. No respiratory problems. Pain has lasted about 3 days but is lessening. Pain makes walking difficult.
Received Janssen vaccine on at 11:30 am on 9/20/2021 Patient began experiencing flu like symptoms at 5 pm (myalgia, chills, headache, fever). ?What really worried me was at 10:30 pm at night, I had severe nerve pain throughout my back, sciatica, and legs.? It minimally radiated through her arms. She couldn?t remain still, and considered going to the ER but did not. She reported pain 10/10 last night. The severity lasted 45 minutes and subsided after she took 400 mg of Advil. Patient reported that this morning, her nerve pain felt dull, and varied between 2/10 ? 6/10 on pain scale. She also experienced episodes where it ?has been pretty painful. 5-8/10.? Pt reports a loss of color in her skin, her face is ?starkly white?. She has also been experiencing diarrhea. Pt has no history of reaction to other vaccines. The only reaction she has had to medications is severe nausea when taking heavy pain meds. Pt has consulted with her PCP and they recommended she manage her symptoms by taking advil, which she reports taking every few hours. I explained to the patient that she should continue to monitor her symptoms, and that she should contact her PCP again if they worsen. I will be reporting this adverse reaction in VAERS. , RN
Pt. received 2nd dose of COVID vaccine and immediately became cool, clammy and diaphoretic, stating he feels?light headed?. EMS activated, VS 104/71, 88-HR, 98%-O2, 20-Resp., pt. listless, yet remains A&Ox4 & responsive. EMS arrival, patient remains unchanged. EMS obtained blood sugar - 132, and also ran an EKG. Per EMS EKG inconclusive, recommended for transport to ED. Patient to ED with AMR.
3 dimensional hives all over her cheeks / had breakouts o hives intermittently over 4 days; the patient received a dose of PROQUAD instead of MMR II; This spontaneous report was received from a consumer (the patient's mother) and refers to a 5.5 years old female patient. The patient had no concomitant medications, pertinent medical history and no drug reactions or allergies. She was vaccinated with 2 doses of varicella virus vaccine live (Oka/Merck) (VARIVAX) when she was supposed to have them (at 1-year-old).  On an unknown date, the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (exact dose, route of administration, albumin status, vaccination site, lot # and expiry date were not specified) for prophylaxis. On 01-MAY-2019, at the doctor's office, the patient was supposed to receive the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) due to measles outbreak, however she received a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection (exact dose, route of administration, albumin status, vaccination site, lot # and expiry date were not reported) instead.  On 02-MAY-2019, the patient was seen in the physician's office due to 3 dimensional hives all over her cheeks. The consumer reported that the patient had breakouts of hives intermittently over 4 days. No lab diagnostics or studies were performed. The patient received an unspecified treatment due to the event. Product quality complaint (PQC) was not involved.  The outcome of urticaria was reported as recovered/resolved on approximately 06-MAY-2019. The relatedness between the event and the suspect vaccines was not provided.